Stocks & Options
Trading Strategies
Institutional Holdings Directory
SEC Filings TLDR
Analysis Reports
AI Tools
EN
Sign in
Allogene Therapeutics, Inc. Reports Q1 2026 Financial Results
2026-05-13
SEC Filing 10-Q
(0001628280-26-034585)
Please check the link below for details.
Ticker mentioned:
ALLO
Source:
Original SEC Document β